SEC 13F Intelligence

5am Venture Management, LLC / MLTX

5am Venture Management, LLC’s Moonlake Immunotherapeutics Position

Does 5am Venture Management, LLC own Moonlake Immunotherapeutics (MLTX)? Not currently — the last reported position was 282.3K shares worth $13M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q2 2025
Shares
282.3K
% of Portfolio
+5.12%
Quarters Held
10
position exited

Position History MLTX

Reported value by quarter
Q1 ’23: $831,130Q1 ’23Q2 ’23: $18MQ3 ’23: $18MQ3 ’23Q4 ’23: $18MQ1 ’24: $14MQ1 ’24Q2 ’24: $12MQ3 ’24: $14MQ3 ’24Q4 ’24: $15MQ1 ’25: $11MQ1 ’25Q2 ’25: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025282.3K$13M+5.12%
Q1 2025282.3K$11M+4.17%
Q4 2024282.3K$15M+3.65%
Q3 2024282.3K$14M+2.94%
Q2 2024282.3K$12M+2.78%
Q1 2024282.3K$14M+3.18%
Q4 2023302.6K$18M+4.85%
Q3 2023313.2K$18M+5.14%
Q2 2023357.5K$18M+4.54%
Q1 202338.9K$831,130+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 5am Venture Management, LLC’s full portfolio or all institutional holders of MLTX.